Takara Bio USA Competitors and Similar CompaniesClear all

Takara Bio USA's competitors and similar companies include HTG Molecular, BG Medicine, FYR Diagnostics and Enopace Biomedical.

	Takara Bio USA Takara Bio USA (formerly known as Clontech Laboratories) is a company that specializes in biochemistry tools.	HTG Molecular HTG Molecular Diagnostics is a company that specializes in precision medicine.	BG Medicine BG Medicine is a life sciences company that develops biomarker-based diagnostic tests for the cardiovascular sectors.	FYR Diagnostics FYR Diagnostics is a biotechnology company that develops polymerase chain reaction (PCR)-focused solutions.	Enopace Biomedical Enopace Biomedical is a biotechnology company that focuses on developing a medical device to treat heart failure.
Founding Date	Founding Date 1984	Founding Date 1997	Founding Date 2000	Founding Date N/A	Founding Date 2008
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech genetics life sciences medical diagnostics	Tags Healthcare biotech genetics life sciences medical diagnostics platform	Tags Healthcare genetics life sciences medical diagnostics	Tags Healthcare bioengineering biotech genetics life sciences medical diagnostics	Tags Healthcare biotech genetics life sciences medical devices medical diagnostics
Locations	Locations San Jose, US HQ Saint Germain En Laye, FR New Delhi, IN Kusatsu, JP Göteborg, SE see more	Locations Tucson, US HQ	Locations Plainville, US HQ	Locations Missoula, US HQ Frenchtown, US Hamilton, US Hamilton, US Kalispell, US	Locations Caesarea, IL HQ
Employees	Employees 2911% increase	Employees 31	Employees 40	Employees 176% increase	Employees N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $6.4m (FY, 2022)	Revenue (est.) $1.6m (FY, 2015)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $4.6m (FY, 2022)	Cost of goods $505k (FY, 2015)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $1.8m (FY, 2022)	Gross profit $1.1m (FY, 2015)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($21.6m) (FY, 2022)	Net income ($5.3m) (FY, 2015)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 69.7m	Total funding raised $ 107m	Total funding raised N/A	Total funding raised N/A